RxDoctor Payments Data

Alan Koff

Infectious Disease · Sacramento, CANPI 1407239700

Payments from drug & device makers

$238,654in general payments, 2019–2025

Across 8 payments — averaging $29,832 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astrazeneca UK Limited$184K
  • Pfizer$55K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astrazeneca UK Limited3$183,878
Pfizer5$54,776

How this compares

$238,654 in reported general payments places this provider in the 90th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California

Medicare billing

Part B allowed, 2024
$44,139
Medicare patients
145
Services billed
491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala33$132,143
JulucaDolutegravir/Rilpivirine18$95,888
Fluconazole11$456
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$313
Cephalexin12$138

Paid to pharmacies, not to this prescriber.

Other infectious disease in Sacramento

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →